| scholarly article | Q13442814 |
| P356 | DOI | 10.4161/GMIC.1.4.12520 |
| P953 | full work available at URL | http://www.tandfonline.com/doi/pdf/10.4161/gmic.1.4.12520 |
| https://doi.org/10.4161/gmic.1.4.12520 | ||
| https://europepmc.org/articles/PMC3023603 | ||
| https://europepmc.org/articles/PMC3023603?pdf=render | ||
| https://www.tandfonline.com/doi/pdf/10.4161/gmic.1.4.12520?needAccess=true | ||
| P932 | PMC publication ID | 3023603 |
| P698 | PubMed publication ID | 21327028 |
| P5875 | ResearchGate publication ID | 49841652 |
| P50 | author | Benjamin P. Willing | Q91169213 |
| P2093 | author name string | B. Brett Finlay | |
| Navkiran Gill | |||
| P2860 | cites work | Journal of Clinical Investigation | Q3186904 |
| IgA response to symbiotic bacteria as a mediator of gut homeostasis | Q79841107 | ||
| Active Crohn's disease and ulcerative colitis can be specifically diagnosed and monitored based on the biostructure of the fecal flora | Q80123941 | ||
| Characterization of FOXP3+CD4+ regulatory T cells in Crohn's disease | Q81357285 | ||
| Is the Th1/Th2 paradigm of immune regulation applicable to IBD? | Q82072001 | ||
| Interleukin-10 and the interleukin-10 receptor | Q24290912 | ||
| The Orphan Receptor CRF2-4 Is an Essential Subunit of the Interleukin 10 Receptor | Q24309259 | ||
| Cell differentiation is a key determinant of cathelicidin LL-37/human cationic antimicrobial protein 18 expression by human colon epithelium | Q24537181 | ||
| Reduced Paneth cell alpha-defensins in ileal Crohn's disease | Q24538724 | ||
| Diversity of the human intestinal microbial flora | Q24544241 | ||
| Symbiotic bacteria direct expression of an intestinal bactericidal lectin | Q24644003 | ||
| Paneth cells directly sense gut commensals and maintain homeostasis at the intestinal host-microbial interface | Q24644721 | ||
| Innate immunity and intestinal microbiota in the development of Type 1 diabetes | Q24647312 | ||
| Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine | Q24648636 | ||
| A core gut microbiome in obese and lean twins | Q24649648 | ||
| Escherichia coli strains colonising the gastrointestinal tract protect germfree mice against Salmonella typhimurium infection | Q24669669 | ||
| CD4+CD25+ T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms | Q24673863 | ||
| Extracellular phospholipase A2 expression and inflammation: the relationship with associated disease states | Q40788881 | ||
| Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression. | Q40961532 | ||
| Extracellular MUC3 mucin secretion follows adherence of Lactobacillus strains to intestinal epithelial cells in vitro | Q42282244 | ||
| Mucosal flora in inflammatory bowel disease | Q43503928 | ||
| Colonic fermentation as affected by antibiotics and acidic pH: Application of an in vitro model. | Q43846012 | ||
| Critical roles of activation-induced cytidine deaminase in the homeostasis of gut flora | Q44218058 | ||
| Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility | Q44808056 | ||
| Long-term ecological impacts of antibiotic administration on the human intestinal microbiota | Q46878665 | ||
| Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria | Q47962035 | ||
| Segmented filamentous bacteria are indigenous intestinal bacteria that activate intraepithelial lymphocytes and induce MHC class II molecules and fucosyl asialo GM1 glycolipids on the small intestinal epithelial cells in the ex-germ-free mouse | Q48076797 | ||
| Chronic enteric salmonella infection in mice leads to severe and persistent intestinal fibrosis | Q50063681 | ||
| Secreted enteric antimicrobial activity localises to the mucus surface layer | Q50064395 | ||
| A full flora, but not monocolonization by Escherichia coli or lactobacilli, supports tolerogenic processing of a fed antigen | Q54484196 | ||
| Shotgun metaproteomics of the human distal gut microbiota | Q56978437 | ||
| Twin studies reveal specific imbalances in the mucosa-associated microbiota of patients with ileal Crohn's disease | Q57129932 | ||
| Dominant-negative TLR5 polymorphism reduces adaptive immune response to flagellin and negatively associates with Crohn's disease | Q57307944 | ||
| Host-Mediated Inflammation Disrupts the Intestinal Microbiota and Promotes the Overgrowth of Enterobacteriaceae | Q57932930 | ||
| Specificities of the fecal microbiota in inflammatory bowel disease | Q58065017 | ||
| Rapid and Noninvasive Metabonomic Characterization of Inflammatory Bowel Disease | Q59880162 | ||
| The adherent gastrointestinal mucus gel layer: thickness and physical state in vivo | Q73727591 | ||
| A primitive T cell-independent mechanism of intestinal mucosal IgA responses to commensal bacteria | Q73919528 | ||
| Host-microbial symbiosis in the mammalian intestine: exploring an internal ecosystem | Q74626882 | ||
| Probiotics up-regulate MUC-2 mucin gene expression in a Caco-2 cell-culture model | Q78626902 | ||
| Intestinal IgA synthesis: a primitive form of adaptive immunity that regulates microbial communities in the gut | Q79426180 | ||
| Effect of Lactobacillus paracasei NCC2461 on antigen-specific T-cell mediated immune responses in aged mice | Q79609846 | ||
| Salmonella enterica serovar typhimurium exploits inflammation to compete with the intestinal microbiota | Q27334139 | ||
| Genomic and metabolic studies of the impact of probiotics on a model gut symbiont and host | Q27335019 | ||
| An obesity-associated gut microbiome with increased capacity for energy harvest | Q27860515 | ||
| Host-bacterial mutualism in the human intestine | Q27861037 | ||
| Induction of intestinal Th17 cells by segmented filamentous bacteria | Q28131638 | ||
| Commensal host-bacterial relationships in the gut | Q28188763 | ||
| Cutting edge: bacterial flagellin activates basolaterally expressed TLR5 to induce epithelial proinflammatory gene expression | Q28211358 | ||
| Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17 | Q28213628 | ||
| Towards the human intestinal microbiota phylogenetic core | Q28251918 | ||
| TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells | Q28296956 | ||
| Aberrant expansion of segmented filamentous bacteria in IgA-deficient gut | Q28505481 | ||
| Increased diversity of intestinal antimicrobial peptides by covalent dimer formation | Q28505962 | ||
| Regulation of spontaneous intestinal tumorigenesis through the adaptor protein MyD88 | Q28512135 | ||
| Bacterial population and innate immunity-related genes in rat gastrointestinal tract are altered by vitamin A-deficient diet | Q28572844 | ||
| The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria | Q28594441 | ||
| Evolution of mammals and their gut microbes | Q28755326 | ||
| Ecological and evolutionary forces shaping microbial diversity in the human intestine | Q29547586 | ||
| Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis | Q29547656 | ||
| Interleukin-10-deficient mice develop chronic enterocolitis | Q29547881 | ||
| Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients | Q29614261 | ||
| An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system | Q29614267 | ||
| Factors influencing the composition of the intestinal microbiota in early infancy | Q29614578 | ||
| The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing | Q29615054 | ||
| Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach | Q29617547 | ||
| Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites | Q29619788 | ||
| Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis | Q29620506 | ||
| Developmental regulation of intestinal angiogenesis by indigenous microbes via Paneth cells | Q30476839 | ||
| Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease | Q33201542 | ||
| Enteric salmonellosis disrupts the microbial ecology of the murine gastrointestinal tract | Q33312411 | ||
| Molecular analysis of the gut microbiota of identical twins with Crohn's disease | Q33327494 | ||
| Specific antibody activity, glycan heterogeneity and polyreactivity contribute to the protective activity of S-IgA at mucosal surfaces | Q33347255 | ||
| Antibiotic-induced perturbations of the intestinal microbiota alter host susceptibility to enteric infection | Q33357471 | ||
| The search for disease-associated compositional shifts in bowel bacterial communities of humans | Q33368533 | ||
| Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine | Q33409985 | ||
| Clinical utility of serological markers in inflammatory bowel disease. | Q33447603 | ||
| Innate and adaptive immunity cooperate flexibly to maintain host-microbiota mutualism | Q37062373 | ||
| Characterizing a model human gut microbiota composed of members of its two dominant bacterial phyla | Q37138595 | ||
| Host-bacteria homeostasis in the healthy and inflamed gut. | Q37214345 | ||
| Factors influencing the establishment of the intestinal microbiota in infancy | Q37216109 | ||
| Enhanced transcription of complement and coagulation genes in the absence of adaptive immunity. | Q37326731 | ||
| Nod2 is required for the regulation of commensal microbiota in the intestine | Q37354181 | ||
| Clinical evidence for immunomodulatory effects of probiotic bacteria. | Q37380570 | ||
| Reciprocal interactions between commensal bacteria and gamma delta intraepithelial lymphocytes during mucosal injury | Q37391313 | ||
| Regulatory mechanisms of immune responses to intestinal bacteria | Q37406887 | ||
| Regulatory lymphocytes and intestinal inflammation. | Q37419380 | ||
| The gut microbiota as a target for improved surgical outcome and improved patient care | Q37481947 | ||
| Enteric defensins are essential regulators of intestinal microbial ecology | Q37483232 | ||
| Postnatal changes in biosynthesis of microvillus membrane glycans of rat small intestine: I. Evidence of a developmental shift from terminal sialylation to fucosylation | Q38353175 | ||
| Differential roles of segmented filamentous bacteria and clostridia in development of the intestinal immune system. | Q39613039 | ||
| Mechanisms of neonatal mucosal antibody protection. | Q39772470 | ||
| Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease | Q39902875 | ||
| Metabolomics reveals metabolic biomarkers of Crohn's disease | Q33487783 | ||
| Influences of microbiota on intestinal immune system development | Q33610638 | ||
| Natural killer cells in antiviral defense: function and regulation by innate cytokines | Q33652468 | ||
| Innate mechanisms of epithelial host defense: spotlight on intestine | Q33731933 | ||
| Th17 cells: effector T cells with inflammatory properties | Q33732092 | ||
| Spatial organization and composition of the mucosal flora in patients with inflammatory bowel disease | Q33885072 | ||
| Influence of major histocompatibility complex on bacterial composition of fecal flora | Q34006859 | ||
| Bactericidal properties of murine intestinal phospholipase A2. | Q34200767 | ||
| Mucosal immunity and viral infections | Q34259769 | ||
| NK cells and NKT cells in innate defense against viral infections | Q34332682 | ||
| Virulence properties of Escherichia coli strains isolated from patients with inflammatory bowel disease | Q34395283 | ||
| TLR signaling in the gut in health and disease | Q34409408 | ||
| Cathelicidins--a family of multifunctional antimicrobial peptides. | Q34534231 | ||
| Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits | Q34596030 | ||
| Antimicrobial polypeptides | Q35213807 | ||
| Culture-independent analyses of temporal variation of the dominant fecal microbiota and targeted bacterial subgroups in Crohn's disease | Q35220907 | ||
| Card15 gene overexpression in mononuclear and epithelial cells of the inflamed Crohn's disease colon | Q35595687 | ||
| Activation of RegIIIbeta/gamma and interferon gamma expression in the intestinal tract of SCID mice: an innate response to bacterial colonisation of the gut. | Q35597375 | ||
| Bacterial contributions to mammalian gut development | Q35682785 | ||
| High prevalence of Escherichia coli belonging to the B2+D phylogenetic group in inflammatory bowel disease | Q35929551 | ||
| Mammalian defensins in the antimicrobial immune response | Q36134856 | ||
| Deletion of TLR5 results in spontaneous colitis in mice | Q36138027 | ||
| Developmental regulation of cryptdin, a corticostatin/defensin precursor mRNA in mouse small intestinal crypt epithelium | Q36220600 | ||
| IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis | Q36303708 | ||
| A molecular sensor that allows a gut commensal to control its nutrient foundation in a competitive ecosystem | Q36436689 | ||
| TLRs in the Gut I. The role of TLRs/Nods in intestinal development and homeostasis. | Q36537785 | ||
| Induction of secretory immunity and memory at mucosal surfaces | Q36709727 | ||
| Reciprocal gut microbiota transplants from zebrafish and mice to germ-free recipients reveal host habitat selection | Q36821642 | ||
| Symbiotic gut microbes modulate human metabolic phenotypes | Q36883096 | ||
| The normal intestinal microbiota. | Q36925502 | ||
| Systemic multicompartmental effects of the gut microbiome on mouse metabolic phenotypes. | Q36973016 | ||
| Innate and adaptive mechanisms to control [corrected] pathological intestinal inflammation | Q37045757 | ||
| Role of Toll-like receptors in gastrointestinal malignancies | Q37051035 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 213-223 | |
| P577 | publication date | 2010-03-04 | |
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | Gut microbes | Q26841922 |
| P1476 | title | The role of the immune system in regulating the microbiota | |
| P478 | volume | 1 |
| Q43966192 | Association of maternal education, early infections, and antibiotic use with celiac disease: a population-based birth cohort study in northeastern Italy |
| Q57287944 | Critical Role for a Subset of Intestinal Macrophages in Shaping Gut Microbiota in Adult Zebrafish |
| Q34207728 | Data mining the human gut microbiota for therapeutic targets |
| Q64085476 | Development and Function of the Intestinal Microbiome and Potential Implications for Pig Production |
| Q34515084 | Early infections are associated with increased risk for celiac disease: an incident case-referent study |
| Q58794811 | Exploring the Impact of the Biofloc Rearing System and an Oral WSSV Challenge on the Intestinal Bacteriome of |
| Q51118909 | Infection, antibiotic therapy and risk of colorectal cancer: a nationwide nested case-control study in patients with Type 2 diabetes mellitus. |
| Q35161373 | Irritable bowel syndrome, gut microbiota and probiotics. |
| Q35721283 | Network analysis of temporal functionalities of the gut induced by perturbations in new-born piglets |
| Q26774779 | Obesity-Driven Gut Microbiota Inflammatory Pathways to Metabolic Syndrome |
| Q35159836 | Reprograming of gut microbiome energy metabolism by the FUT2 Crohn's disease risk polymorphism |
| Q34455427 | Role of secretory IgA in the mucosal sensing of commensal bacteria |
| Q41853097 | The Commensal Microbiota Drives Immune Homeostasis |
| Q36407888 | The Role of Secretory Immunoglobulin A in the Natural Sensing of Commensal Bacteria by Mouse Peyer's Patch Dendritic Cells |
| Q38115440 | The role of the immune system in governing host-microbe interactions in the intestine |
Search more.